Public Health Laboratories for Alert and Response. A WHO Guidance Document

Size: px
Start display at page:

Download "Public Health Laboratories for Alert and Response. A WHO Guidance Document"

Transcription

1

2 Public Health Laboratories for Alert and Response A WHO Guidance Document

3 WHO Library Cataloguing in Publication Data Public health laboratories for alert and response: a WHO guidance document 1. Laboratories - standards. 2. Public health. 3. Disease outbreaks. 4. Quality control. I. World Health Organization Regional Office for the Western Pacific. ISBN (NLM Classification: WA 23) World Health Organization 2012 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: ; fax: ; bookorders@who.int). Requests for permission to reproduce or translate WHO publications whether for sale or for noncommercial distribution should be addressed to WHO Press, at the above address (fax: ; permissions@who.int). For WHO Western Pacific Regional Publications, request for permission to reproduce should be addressed to the Publications Office, World Health Organization, Regional Office for the Western Pacific, P.O. Box 2932, 1000, Manila, Philippines, (fax: , publications@wpro.who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.

4 A WHO Guidance Document Contents Acknowledgements.... iv Abbreviations.... v 1. Introduction Public health laboratory system Core functions of public health laboratories Support public health surveillance Support outbreak response Act as a national resource and coordinating centre Factors to consider when establishing public health laboratories Syndromic approach to laboratory testing Diagnostic capability Staffing Physical structure, equipment and supplies Biosafety Laboratory information management system Quality assurance External quality assessment Quality control International quality standards References iii

5 Public Health Laboratories for Alert and Response Acknowledgements The authors would like to acknowledge the following experts for their contributions to the preparation of this guidance document: Dr Chua Kaw Bing, Temasek Life Sciences Laboratory, Singapore; Dr Abdul Rasid Kasri, Ministry of Health, Malaysia; Ms Supawat Krongkaew, National Institute of Health, Thailand; Dr Raymond Lin, Ministry of Health, Singapore; Dr Yoshitsugu Miyazaki, National Institute of Infectious Diseases, Japan; and Dr Feng Zijian, Centers for Disease Control, China. iv

6 A WHO Guidance Document Abbreviations AMR APSED EID EQA HFMD IHR ISO JE NIID NIH PCR WHO antimicrobial resistance Asia Pacific Strategy for Emerging Diseases emerging infectious disease external quality assurance hand, foot and mouth disease International Health Regulations International Organization for Standardization Japanese encephalitis National Institute of Infectious Diseases National Institute of Health polymerase chain reaction World Health Organization v

7

8 1 Introduction Emerging infectious diseases (EIDs), including diseases caused by antimicrobial-resistant pathogens, can potentially cause regional and global outbreaks. The International Health Regulations, also known as IHR (2005), provide the legal framework for collective action by WHO and Member States to prepare for and respond to EIDs that may cross borders and pose threats to health security. 1 To ensure early recognition of EIDs, and to minimize their impact on health, society and economies, WHO and its Member States are strengthening national and regional capacity to rapidly and accurately identify causative pathogens. Reliable and timely laboratory diagnosis is a crucial component of such capacity. The Asia Pacific Strategy for Emerging Diseases (APSED) was launched in 2005 as a common strategic framework for countries and areas in the 1

9 Public Health Laboratories for Alert and Response Western Pacific and South-East Asian Regions to strengthen their capacity to manage and respond to emerging disease threats, and to meet the core capacity requirements under IHR (2005). The updated strategy, APSED (2010), consists of eight focus areas to assist Member States in the region to develop and implement core capacities. 2 Focus area two of this strategy is laboratory strengthening, which strongly contributes to other core capacities such as surveillance, risk assessment and outbreak response (Figure 1). The purpose of this guidance document is to assist Member States in establishing a public health diagnostic laboratory network to support surveillance activities and enhance rapid detection and response to EID outbreaks. This document describes the public health laboratory system, its core functions, and factors to consider when establishing such a system. Figure 1: The relationship between surveillance, risk assessment and outbreak response for emerging infectious diseases Event-based Surveillance Clusters of disease Rumors of unexplained deaths Time frame for reporting: Immediate Indicator-based Surveillance Sentinel and laboratory-based Time frame for reporting: Weekly or monthly Risk Assessment Response National and subnational capacities to respond to alerts 2

10 A WHO Guidance Document 2 Public health laboratory system Health laboratory services, which have been detailed in the Asia Pacific Strategy for Strengthening Health Laboratory Services ( ), 3 are instrumental to health systems. Public health laboratories play an important role in providing these services. A public health laboratory is broadly defined as a government laboratory funded by public money that performs activities related to protection, support and promotion of health-related matters. Public health laboratories can be classified into three categories: 1. diagnostic laboratories, including: a. hospital-based laboratories, and b. community-based laboratories; 2. reference laboratories; and 3. research laboratories. 3

11 Public Health Laboratories for Alert and Response Non-public health diagnostic laboratories are referred to as clinical laboratories in this document. An integrated public health laboratory system, which includes a network of all three categories of laboratories (diagnostic, reference and research), aims to improve laboratory capacity and efficiency to support surveillance and outbreak response. It also serves to harmonize the different laboratories in order to enhance and complement their individual roles. Public health diagnostic laboratories are at the base of an integrated public health laboratory system (Figure 2). 4 They are close to the point of patient care and serve as the first line of support for epidemiological surveillance and response, including the confirmation of known diseases and the recognition of novel or (re-)emerging diseases. Just as in clinical practice, where the general practitioner is the first point of contact for patients before referral to specialists, the diagnostic laboratory is the point of entry for a specimen before being sent to a pathogen-specific laboratory. Public health diagnostic laboratories should be able to identify a range of pathogens commonly associated with a clinical condition, using readily available reagents and methods. Difficult or unusual cases, as well as cases with negative results, may then be referred to a reference laboratory for more specialized investigations (Figure 2). The establishment of an in-country public health laboratory system is important for an effective and rapid response to new infections with epidemic or pandemic potential. The integrated system will include reference laboratories that are able to identify pathogens of public health significance. 4

12 A WHO Guidance Document Figure 2: Schematic representation of an integrated public health laboratory system in Country X Reference Laboratory International Not characterized EQA programmes Country X Not characterized Reference Laboratory Reference Laboratory National level EQA programmes Biosafety PHDL PHDL PHDL Sub-national level Notes: Public health diagnostic laboratories (indicated as PHDL) are at the base (subnational level) of the network. Specimens are sent to reference laboratories at the national level and, if necessary, to a reference laboratory outside the country. External quality assessment (EQA) programmes provided by national and international reference laboratories assure the quality of diagnostic tests conducted at the subnational and national levels, respectively. 5

13 Public Health Laboratories for Alert and Response Laboratories in a functional network communicate with each other, with epidemiology departments and with higher authorities, e.g. government or relevant ministries. The aim of the network is to provide advice and share expertise to strengthen national and regional capacity for surveillance and timely response. The approach used to establish a national public health laboratory network depends very much on a country s structure, size, demography, financial resources, availability of human expertise and technological resources. For a country with a small population size, the national public health diagnostic laboratory could merge with one of the clinical laboratories for optimal function and sustainability. 2.1 Core functions of public health laboratories The sections below explain the following core functions of public health laboratories: 1. support public health surveillance; 2. support outbreak response; and 3. act as a national resource and coordinating centre Support public health surveillance Public health diagnostic laboratories support surveillance by monitoring the presence of pathogens and disease trends. They are responsible for providing guidance related to collecting appropriate patient specimens, selecting and performing diagnostic tests, further typing of agents such as antimicrobial resistance (AMR), and, in case the causative agent cannot be characterized on site, referral of the specimens to reference laboratories (Figure 2). 6

14 A WHO Guidance Document Case study 1: Laboratory networks in Japan during an outbreak response A major outbreak of febrile encephalitis affecting pigs and humans in peninsular Malaysia in resulted in the death of 105 humans and the eventual culling of about 1.1 million pigs. The outbreak, which initially affected pig farm workers, Before was officially pandemic reported influenza September A(H1N1) cases 1998, were in the detected suburb in of Japan, Ipoh, the National capital Institute city of Perak of Infectious state, situated Diseases in the (NIID) north-western and subnational part of (regional) peninsular laboratories were Malaysia. trained From on this the epicentre, use of polymerase the outbreak chain spread reaction to other (PCR) parts for detection of peninsular of pandemic Malaysia influenza and reached A(H1N1) Singapore strains. by NIID March supported As the soon subnational as the outbreak laboratories was with the recognized provision in late of 1998, a detection the Ministry package, of Health consisting of Malaysia of the protocols, carried out primers various and enzymes measures specific to control for pandemic a JE epidemic, influenza but A(H1N1). they failed The to control subnational the disease. laboratories The tested all discovery clinical of Nipah samples, virus but as the only causative specimens agent with of positive the outbreak or ambiguous in mid-march results 1999 were sent was a significant to NIID for turning confirmatory point testing. instituting Thanks the to correct this subnational control measures laboratory and network, terminating specimens the outbreak. were tested As a close lesson to learnt, the front-line Malaysia and now the undertakes surveillance laboratory system was testing updated using clinical without symptoms delay. With and surge epidemiological capacity of findings human resources rather than across the country, following the the burden previous on NIID practice has been of disease-specific reduced. use of diagnostics. 5 7

15 Public Health Laboratories for Alert and Response National reference laboratories are encouraged to train and build capacity at the subnational level to build surge capacity in case of a disease outbreak. They need to ensure that laboratory standards, including biosafety, are maintained at the subnational level. EQA programmes for diagnosis of EIDs, organized by the national laboratories, need to be conducted to ensure accurate and reliable diagnosis Support outbreak response In the event of an outbreak of EID, public health diagnostic laboratories will play a crucial role in supporting hospital-based clinical laboratories with the timely identification of the causative agent to ensure the rapid institution of appropriate control measures. Following the detection of the causative pathogen of an outbreak, the public health diagnostic laboratory should refer the pathogen to national or regional reference laboratories for confirmation or identification, or for further characterization. In the event of an outbreak of EID due to a novel pathogen, a system needs to be in place to enable the timely characterization of the pathogen for appropriate response. This referral system will be based on the existing surveillance system but will use standard operating procedures for rapid referral of specimens, will prioritize outbreak specimens for testing and will ensure round-the-clock availability of staff. Such a system should also include a mechanism for surge capacity to scale up diagnostic support. For any disease outbreak, known pathogens are always present along with the causative agent of the outbreak. Thus, epidemiological information, clinical features as well as pathological findings need to be correlated with laboratory findings in order to build enough evidence for the final 8

16 A WHO Guidance Document diagnosis of the causative pathogen. Therefore, as in the case of public health surveillance work, clinicians, epidemiologists, clinical laboratories and public health diagnostic laboratories have to work together to ensure early detection and response to EID threats Act as a national resource and coordinating centre An integrated public health laboratory system requires well-structured organization, strong leadership and streamlined coordination to function optimally and sustainably. The national public health laboratory or national public reference laboratory can act as the country s resource and coordinating centre for all laboratory-related matters. It can act as a resource pool for the country s laboratory expertise and maintain close links with public health experts in country as well as with regional and international reference systems. The national public health laboratory should support the development and implementation of national laboratory policy, establish and coordinate a functional national laboratory quality system, provide training in diagnostic techniques and biosafety procedures, and monitor AMR, where applicable. 9

17 Public Health Laboratories for Alert and Response Case study 2: The Thai National Institute of Health and support of subnational public health laboratories in Thailand The National Institute of Health (NIH) is the national public health reference laboratory of Thailand. It supports 14 regional medical science centres with subnational public health laboratories. During outbreak situations, NIH participates in the national emergency operation centre organized by the Department of Disease Control, Ministry of Public Health. For laboratory issues, NIH organizes videoconferences with subnational laboratories to discuss how to support epidemiological surveillance and outbreak response. NIH organizes training workshops and refresher courses for staff of the subnational laboratories and provides support in terms of guidelines, standard operating procedures, reagents, quality control samples, and transport media for influenza A(H1N1)pdm09, EHEC O 104, and hand, foot and mouth disease (HFMD). Molecular techniques for all pathogens were transferred to subnational laboratories. Previously, samples that tested positive by PCR were transferred to NIH for confirmation, isolation and typing, but these techniques are now available at subnational laboratories. All laboratory results are sent to NIH for collation and analysis, and policy-makers are informed on a daily basis. Between outbreaks, NIH conducts nationwide proficiency testing to ensure laboratories maintain competency in testing methods. 10

18 3 Factors to consider when establishing public health laboratories 3.1 Syndromic approach to laboratory testing Generally, public health laboratories focus on specific agents, such as Japanese encephalitis (JE) or influenza, rather than on clinical presentation, such as encephalitis or pneumonia. To enhance detection and identification of diseases that cause outbreaks, a system must be built to identify a full range of pathogens based on clinical presentation and epidemiological findings. 3.2 Diagnostic capability Each laboratory performs only a certain number of diagnostic tests. Each type of diagnostic test has its advantages and disadvantages in terms of cost, technological sophistication, sensitivity and specificity, as well as result interpretation. Laboratory tests should be carefully selected to help public health specialists make the correct diagnosis. 11

19 Public Health Laboratories for Alert and Response Case study 3: A lesson from Malaysia A major outbreak of febrile encephalitis affecting pigs and humans in peninsular Malaysia in resulted in the death of 105 humans and the eventual culling of about 1.1 million pigs. The outbreak, which initially affected pig farm workers, was officially reported in September 1998, in the suburb of Ipoh, the capital city of Perak state, situated in the north-western part of peninsular Malaysia. From this epicentre, the outbreak spread to other parts of peninsular Malaysia and reached Singapore by March As soon as the outbreak was recognized in late 1998, the Ministry of Health of Malaysia carried out various measures to control a JE epidemic, but they failed to control the disease. The discovery of Nipah virus as the causative agent of the outbreak in mid-march 1999 was a significant turning point in instituting the correct control measures and terminating the outbreak. As a lesson learnt, Malaysia now undertakes laboratory testing using clinical symptoms and epidemiological findings rather than following the previous practice of disease-specific use of diagnostics. 5 12

20 A WHO Guidance Document With the increasing concern for AMR, laboratory-based surveillance for AMR is becoming more important. There is a need for laboratories that can detect the presence of resistance, as well as reference facilities able to identify important new resistance genes. AMR surveillance data may be used to inform clinical management, educate medical practitioners about antibiotic prescribing practices and monitor the effectiveness of infection control activities. 3.3 Staffing Laboratories need staff who possess the necessary technical skills to deliver an effective quality of service. A comprehensive programme should be developed at the country level to assess training needs and provide training. Staff training should cover new technologies along with upgrading known methods. 3.4 Physical structure, equipment and supplies The national coordinating centre should ensure that laboratories are built according to standards required for their function, and that they incorporate appropriate biosafety measures. 3.5 Biosafety Staff who work with infectious microbiological agents are at risk of laboratory-acquired infection and of accidentally spreading infectious material to the public. Hence, laboratory staff need to be aware of potential hazards and should be trained in the safe handling of such 13

21 Public Health Laboratories for Alert and Response materials. Biosafety involves good staff training, the availability of standard operating procedures, staff competence in risk management, appropriate containment equipment, proper facility design, correct operation and maintenance, and administrative considerations to minimize the risk of worker injury or illness or environmental contamination. 6 Biosafety practices must be engaged at every step from sample collection, transportation, processing and testing, to storage and waste management. Errors in any one part of the chain will result in risks to biosafety. Biosafety requires appropriate physical infrastructure, including engineering controls and equipment maintenance. 3.6 Laboratory information management system A laboratory information management system would enhance alert and response as it allows for the capture, analysis and storage of laboratory surveillance data, and ensures timely sharing of relevant data with those who need to be informed for public health action. The system may be electronic, allowing for real-time communication with hospitals and epidemiology units, or it may be paper-based but with provisions, allowing for the timely alerting of relevant parties involved in follow-up control action. 14

22 4 Quality assurance Laboratory quality assurance is the process whereby the quality of laboratory reports can be guaranteed. Laboratory quality assurance is a combination of quality control and internal and external quality assessment. Quality control covers the analytical part of quality assurance. Recent documents describe the main requirements and the implementation of laboratory quality standards. 7,8 The sections below describe EQA, quality control and quality standards in more detail. 4.1 External quality assessment EQA is the assessment of the quality of laboratory performance by comparing test results between laboratories. Oftentimes, several laboratories are provided with identical sets of coded samples and controls (or proficiency test panel) that have been prepared by a reference laboratory. Once the tests have been completed the laboratories send the results to the reference laboratory to determine the accuracy of the 15

23 Public Health Laboratories for Alert and Response individual laboratories. Examples of diseases for which EQA programmes exist are influenza, measles, tuberculosis and polio. EQA can be conducted at an international level, but it may be difficult for some countries to participate because such programmes can be expensive and shipments may encounter customs delays. As an alternative, national reference laboratories can organize in-country EQA programmes. Many pathogens, due to their unusual nature or occurrence in only developing countries, do not have corresponding EQA programmes. Therefore, other avenues need to be explored to assess quality, such as inter-laboratory exchange of clinical specimens or control materials such as isolates, DNA or positive specimens. 4.2 Quality control Quality control aims to verify test results and to reduce errors in the performance of tests to a minimum. It covers all aspects of microbiological testing, including reagents, equipment and procedures, related to, for example, preparation of culture media or AMR testing. Reagents must be clearly labelled, stored, and used before their expiry date. Equipment must undergo regular cleaning, servicing and maintenance in order to remain in good working order. Establishing and following standard operating procedures are important to ensuring quality control. 16

24 A WHO Guidance Document 4.3 International quality standards The International Organization for Standardization (ISO) has developed standards for quality management of medical laboratories (ISO 15189) and measurement laboratories (ISO 17025). Public health laboratories should strive to be in compliance with these standards. 17

25 Public Health Laboratories for Alert and Response References 1. International Health Regulations (2005), Second Edition. Geneva, WHO, Asia Pacific Strategy for Emerging Diseases (2010). WHO Regional Offices for South-East Asia and the Western Pacific, Asia Pacific Strategy for Strengthening Health Laboratory Services ( ). WHO Regional Offices for South-East Asia and the Western Pacific, Informal Consultation on a Draft Asia Pacific Laboratory Action Plan ( ) for Emerging Infectious Diseases, Manila, Philippines, May Syndromic Notifications and Laboratory Investigation Manual. Kuala Lumpur, Ministry of Health Malaysia, Laboratory Biosafety Manual, Third Edition. Geneva, WHO, Laboratory Quality Standards and their Implementation. WHO Regional Offices for South-East Asia and the Western Pacific, Laboratory Quality Management System Handbook. Geneva, WHO,

26 WHO Western Pacific Region PUBLICATION ISBN

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network Summary report on the Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network WHO-EM/CSR/070/E Sharm el-sheikh, Egypt 24 27 November 2013 Summary

More information

Asia Pacific. for Emerging Diseases

Asia Pacific. for Emerging Diseases Asia Pacific Strategy for Emerging Diseases 2010 South-East Asia Region Western Pacific Region Asia Pacific Strategy for Emerging Diseases 2010 South-East Asia Region Western Pacific Region WHO Library

More information

Pandemic Influenza Preparedness and Response

Pandemic Influenza Preparedness and Response 24 th Meeting of Ministers of Health Dhaka, Bangladesh, 20-21 August 2006 SEA/HMM/Meet.24/4(b) 10 July 2006 Pandemic Influenza Preparedness and Response Regional situation: Human cases and outbreaks of

More information

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES A WHO Library Cataloguing-in-Publication Data Monitoring the building blocks of health systems:

More information

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods INTRODUCTION National Influenza Centres (NICs) are the backbone of the WHO Global Influenza Surveillance

More information

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017 Multidrug-/ rifampicinresistant TB (MDR/RR-TB): Update 2017 The global TB situation (1) Estimated incidence, 2016 Estimated number of deaths, 2016 All forms of TB HIV-associated TB Multidrug- / rifampicin-resistant

More information

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION AFRO Library Cataloguing-in-Publication Data Declaration on Acceleration of HIV Prevention efforts in the African Region 1. Acquired

More information

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

WHO Library Cataloguing-in-Publication Data. World health statistics 2011. WORLD HEALTH STATISTICS 2011 WHO Library Cataloguing-in-Publication Data World health statistics 2011. 1.Health status indicators. 2.World health. 3.Health services - statistics. 4.Mortality. 5.Morbidity.

More information

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans VOLUME 93 Carbon Black, Titanium Dioxide, and Talc LYON, FRANCE 2010

More information

NATIONAL AIDS PROGRAMME MANAGEMENT A SET OF TRAINING MODULES

NATIONAL AIDS PROGRAMME MANAGEMENT A SET OF TRAINING MODULES NATIONAL AIDS PROGRAMME MANAGEMENT A SET OF TRAINING MODULES WHO Library Cataloguing-in-Publication data World Health Organization, Regional Office for South-East Asia. National AIDS programme management:

More information

Guidelines for scaling-up the 100% condom use programme:

Guidelines for scaling-up the 100% condom use programme: Guidelines for scaling-up the 100% condom use programme: Experience from Cambodia World Health Organization Regional Office for the Western Pacific Guidelines for scaling-up the 100% condom use programme:

More information

Photo Book: Identify Signs of Illness

Photo Book: Identify Signs of Illness Integrated Management of Childhood Illness Caring for the Sick Child in the Community Photo Book: Identify Signs of Illness Photo 1 and 2. Chest indrawing Photo 3. Severe malnutrition (marasmus) Photo

More information

NATIONAL COORDINATION MECHANISM FOR TOBACCO CONTROL A Model for the African Region

NATIONAL COORDINATION MECHANISM FOR TOBACCO CONTROL A Model for the African Region NATIONAL COORDINATION MECHANISM FOR TOBACCO CONTROL A Model for the African Region I. World Health Organization. Regional Office for Africa II.Title ISBN 978-929023293-3 NLM Classification: WM 290) WHO

More information

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans biological agents volume 100 B A review of human carcinogens This publication

More information

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive WHO/NMH/TFI/11.3 WHO REPORT on the global TOBACCO epidemic, 2011 Warning about the dangers of tobacco Executive summary fresh and alive World Health Organization 2011 All rights reserved. Publications

More information

MONITORING HEALTH INEQUALITY

MONITORING HEALTH INEQUALITY MONITORING HEALTH INEQUALITY An essential step for achieving health equity ILLUSTRATIONS OF FUNDAMENTAL CONCEPTS The examples in this publication draw from the topic of reproductive, maternal and child

More information

Latent tuberculosis infection

Latent tuberculosis infection Latent tuberculosis infection Updated and consolidated guidelines for programmatic management ANNEX 3 Values and preferences for the management of latent tuberculosis infection: survey of populations affected

More information

WHO Emergency Risk Communication

WHO Emergency Risk Communication WHO Emergency Risk Communication Course Introduction Module A 1 Copyright World Health Organization 2016 All rights reserved The designations employed and the presentation of the material in this publication

More information

Travel and transport risk assessment. Preparedness for potential outbreak of

Travel and transport risk assessment. Preparedness for potential outbreak of Travel and transport risk assessment Preparedness for potential outbreak of Ebola Interim virus guidance disease: for A public framework health for authorities and action the transport in the Western sector

More information

Summary report on the WHO-EM/CSR/124/E

Summary report on the WHO-EM/CSR/124/E Summary report on the Consultative workshop to define an appropriate surveillance strategy for detection of clusters of Zika virus infection and other arboviral diseases using both syndromic- and event-based

More information

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries Summary report on the Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries Casablanca, Morocco 18 20 October

More information

JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014

JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014 JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014 We, the Health Ministers of Brunei Darussalam, Cambodia, Indonesia,

More information

CUTANEOUS LEISHMANIASIS

CUTANEOUS LEISHMANIASIS CUTANEOUS LEISHMANIASIS Why are you neglecting me? A WHO initiative to control Cutaneous Leishmaniasis in selected Old World areas This document has been produced as the result of a WHO Informal Consultative

More information

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net WHO-EM/MAL/367/E Summary report on the Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net Muscat, Oman 22 24 September 2011 World Health Organization 2012

More information

GOOD PHARMACOPOEIAL PRACTICES

GOOD PHARMACOPOEIAL PRACTICES May 2013 RESTRICTED GOOD PHARMACOPOEIAL PRACTICES CONCEPT PAPER ON PURPOSE AND BENEFITS (MAY 2013) DRAFT FOR COMMENT Please address any comments on this proposal by 12 July 2013 to Dr S. Kopp, Medicines

More information

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE DECEMBER 2015 TECHNICAL UPDATE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE DECEMBER 2015 WHO Library

More information

State of InequalIty. Reproductive, maternal, newborn and child health. executi ve S ummary

State of InequalIty. Reproductive, maternal, newborn and child health. executi ve S ummary State of InequalIty Reproductive, maternal, newborn and child health executi ve S ummary WHO/HIS/HSI/2015.2 World Health Organization 2015 All rights reserved. Publications of the World Health Organization

More information

IHR and Asia Pacific Strategy for Emerging Diseases. Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO)

IHR and Asia Pacific Strategy for Emerging Diseases. Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO) IHR and Asia Pacific Strategy for Emerging Diseases Health Security and Emergencies (DSE) Global distribution of relative risk of an Emerging Infectious Disease Event Maps are derived for EID events caused

More information

Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus

Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus 29 April 2009 Introduction The audiences for this guidance document are the National Focal Points for the

More information

BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA

BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA THIS DOCUMENT IS A SUPPLEMENT TO BEST PRACTICES IN MICROPLANNING FOR POLIO ERADICATION. ACKNOWLEDGEMENTS

More information

Ebola: preparedness and solidarity. Ebola virus disease has claimed more than lives. and infected more than people in West Africa

Ebola: preparedness and solidarity. Ebola virus disease has claimed more than lives. and infected more than people in West Africa Ebola: preparedness and solidarity Introduction 1. Testing outbreak preparedness 2. Introducing a team approach for the global response 3. WEST stories from the field 4. What we have learnt Ebola virus

More information

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for

More information

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in

More information

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND 48+ MONTHS DECEMBER 2017 Guidance For Sampling ART

More information

WHO/PSM/PAR/ WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus

WHO/PSM/PAR/ WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus WHO/PSM/PAR/2006.6 WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus World Health Organization 2006 All rights reserved. Publications of the

More information

International Health Regulation update and progress in the region

International Health Regulation update and progress in the region International Health Regulation update and progress in the region 7 th Meeting of CAPSCA Asia Pacific 20-23 May 2014 Colombo, Sri Lanka Dr Bardan Jung Rana International Health Regulation WHO South-East

More information

BEST PRACTICES FOR PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION

BEST PRACTICES FOR PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION THIS DOCUMENT IS A SUPPLEMENT TO BEST PRACTICES IN MICROPLANNING FOR POLIO ERADICATION. ACKNOWLEDGEMENTS These best practices documents for polio

More information

Operational Guidance on Sharing Seasonal Influenza viruses with WHO Collaborating Centres (CCs) under the Global Influenza Surveillance and Response

Operational Guidance on Sharing Seasonal Influenza viruses with WHO Collaborating Centres (CCs) under the Global Influenza Surveillance and Response Operational Guidance on Sharing Seasonal Influenza viruses with WHO Collaborating Centres (CCs) under the Global Influenza Surveillance and Response System (GISRS) 31 October 2017 WHO/WHE/IHM/GIP/2017.6

More information

Diabetes. Halt the diabetes epidemic

Diabetes. Halt the diabetes epidemic Diabetes Halt the diabetes epidemic WHO Library Cataloguing in Publication Data World Health Organization. Regional Office for the Eastern Mediterranean Diabetes: halt the diabetes epidemic / World Health

More information

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs, U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on

More information

WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV) Situation update and overview of available guidance

WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV) Situation update and overview of available guidance WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV) Situation update and overview of available guidance 11 September 2013 Address requests about publications

More information

Strengthening regional health security: Emerging diseases and disaster preparedness and response

Strengthening regional health security: Emerging diseases and disaster preparedness and response TWELFTH PACIFIC HEALTH MINISTERS MEETING PIC12/T6 Rarotonga, Cook Islands 21 August 2017 28 30 August 2017 ORIGINAL: ENGLISH Strengthening regional health security: Emerging diseases and disaster preparedness

More information

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Head of Delegation HERAWATI SUDOYO MD, PHD Eijkman Institute for Molecular Biology Ministry for Research and Technology

More information

Volume 10 Cervix Cancer Screening

Volume 10 Cervix Cancer Screening IARC Handbooks of Cancer Prevention Volume 10 Cervix Cancer Screening International Agency For Research On Cancer The International Agency for Research on Cancer (IARC) was established in 1965 by the World

More information

Module 9 Strategic information

Module 9 Strategic information National AIDS Programme Management A Training Course Module 9 Strategic information 2007 WHO Library Cataloguing-in-Publication data World Health Organization, Regional Office for South-East Asia. National

More information

REPORT ON THE SPECIAL SESSION ON IDENTIFYING THE PUBLIC HEALTH RESEARCH NEEDS FOR INFLUENZA IN AFRICA 4 JUNE 2010, MARRAKESH, MOROCCO

REPORT ON THE SPECIAL SESSION ON IDENTIFYING THE PUBLIC HEALTH RESEARCH NEEDS FOR INFLUENZA IN AFRICA 4 JUNE 2010, MARRAKESH, MOROCCO REPORT ON THE SPECIAL SESSION ON IDENTIFYING THE PUBLIC HEALTH RESEARCH NEEDS FOR INFLUENZA IN AFRICA 4 JUNE 2010, MARRAKESH, MOROCCO World Health Organization This document was prepared by Michael Gordy

More information

Global Alert and Response Against Emerging and Reemerging Infectious Diseases an Overview

Global Alert and Response Against Emerging and Reemerging Infectious Diseases an Overview 63 Global Alert and Response Against Emerging and Reemerging Infectious Diseases an Overview Tomimasa SUNAGAWA Infectious Disease Surveillance Center, National Institute of Infectious Diseases 1-23-1 Toyama,

More information

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

Public health relevant virological features of Influenza A(H7N9) causing human infection in China Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional

More information

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE Sonja Löfmark Public Health Agency of Sweden 6 th BARN Workshop May 12, 2016 Uppsala What is GLASS? A global programme for AMR surveillance The data it collects

More information

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2017, WHO Western Pacific Region

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2017, WHO Western Pacific Region Volume 12 Issue 1 January 2018 ISSN 1814 3601 Figure 1. Incidence rate of total ( compatible) measles with rash onset 1 31 ember, WHO Western Pacific Region Legend: Pacific isl countries areas No

More information

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/

More information

Communication and Integration Strategy

Communication and Integration Strategy ASEAN Plus Three Emerging Infectious Diseases Programme Communication and Integration Strategy Asia-Europe Foundation (ASEF) Network for Public Health Expert Meeting on Regional Integration and Infectious

More information

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data Volume 11 Issue 1 uary 2017 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ember, WHO Western Pacific Region Legend: No confirmed case With confirmed case No case

More information

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Masaya Kato, WHO Viet Nam OIE Regional Workshop on Enhancing Influenza A viruses National Surveillance

More information

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 1. Does my country need JE vaccine?

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 1. Does my country need JE vaccine? Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 1 Does my country need JE vaccine? 1 about this guide Japanese encephalitis (JE), a viral infection of the

More information

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data Volume 11 Issue 3 ch ISSN 1814 3601 Figure 1. Distribution of measles cases with rash onset 1 28 ruary, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at random

More information

1. Zoonoses. 2. Intersectoral cooperation. 3. Guidelines. ISBN (NLM Classification: WC 950)

1. Zoonoses. 2. Intersectoral cooperation. 3. Guidelines. ISBN (NLM Classification: WC 950) WHO Library Cataloguing in Publication Data Zoonotic diseases : a guide to establishing collaboration between animal and human health sectors at the country level. 1. Zoonoses. 2. Intersectoral cooperation.

More information

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data Volume 11 Issue 10 ober ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 30 tember, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at rom within

More information

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2018, WHO Western Pacific Region

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2018, WHO Western Pacific Region Volume 13 Issue 1 uary 2019 ISSN 1814 3601 Figure 1. Incidence rate of total ( and compatible) measles cases with rash onset 1 31 ember, WHO Western Pacific Region Legend: No cases

More information

Legend: No confirmed case With confirmed case** No case based data

Legend: No confirmed case With confirmed case** No case based data Volume 11 Issue 9 September ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 31 ust, WHO Western Pacific Region Legend: No case With case** No case based data Dots are placed at rom within

More information

Legend: No confirmed case With confirmed case No case based data

Legend: No confirmed case With confirmed case No case based data Volume 10 Issue 4 il 2016 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ch 2016, WHO Western Pacific Region Legend: No confirmed case With confirmed case No case

More information

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region Volume 12 Issue 4 April ISSN 1814 3601 Figure 1. Incidence rate of total ( compatible) measles cases with rash onset 1 31 ch, WHO Western Pacific Region Legend: No cases

More information

CRITICAL ELEMENTS OF LABORATORY SUPPORT TO OUTBREAK DETECTION & INVESTIGATION BACKGROUND PAPER

CRITICAL ELEMENTS OF LABORATORY SUPPORT TO OUTBREAK DETECTION & INVESTIGATION BACKGROUND PAPER CRITICAL ELEMENTS OF LABORATORY SUPPORT TO OUTBREAK DETECTION & INVESTIGATION BACKGROUND PAPER Introduction Laboratory diagnosis is an essential element of communicable disease surveillance, both for routine

More information

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej

More information

Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do

Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do Based on current data and information from the Centers for Disease Control (CDC) and the U.S. Department Health and Human Services

More information

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN BULLETIN World Health Organization Regional Office for the Western Pacific Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January

More information

Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria.

Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria. Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria. A paper presented to the Meeting of Experts of States Parties to the Biological Weapons Convention,

More information

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 March 2014

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 March 2014 Volume 8 Issue 4 il 2014 ISSN 1814 3601 Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 ch 2014 1 dot = 1 case Confirmed cases Australia 33 Brunei Darussalam 0 Cambodia 0 China 7675

More information

THE SOUTH-EAST ASIA AND CHINA FOOT- AND-MOUTH DISEASE 2020 ROADMAP AND CONTEXT

THE SOUTH-EAST ASIA AND CHINA FOOT- AND-MOUTH DISEASE 2020 ROADMAP AND CONTEXT THE SOUTH-EAST ASIA AND CHINA FOOT- AND-MOUTH DISEASE 2020 ROADMAP AND CONTEXT REGIONAL INFORMATION SEMINAR FOR RECENTLY APPOINTED OIE DELEGATES BEIJING, P.R. CHINA 28-30 APRIL 2014 Karanvir Kukreja OIE

More information

Summary report on the WHO-EM/WRH/104/E

Summary report on the WHO-EM/WRH/104/E Summary report on the Training of trainers course for national gynaecology and obstetrics societies and midwifery associations on evidence-based guidelines for strengthening family planning services WHO-EM/WRH/104/E

More information

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012) July 2012 RESTRICTED PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012) PROPOSED REVISION FOR COMMENT The background

More information

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 January 2014

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 January 2014 Volume 8 Issue 2 ruary 2014 ISSN 1814 3601 Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 uary 2014 1 dot = 1 case Confirmed cases Australia 70 Brunei Darussalam 0 Cambodia 0 China

More information

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for

More information

Overheads. Complementary Feeding Counselling a training course. World Health Organization

Overheads. Complementary Feeding Counselling a training course. World Health Organization Overheads Complementary Feeding Counselling a training course World Health Organization WHO Library Cataloguing-in-Publication Data World Health Organization. Complementary feeding counselling : training

More information

WORLD HEALTH ORGANIZATION

WORLD HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION FIFTY-FOURTH WORLD HEALTH ASSEMBLY A54/9 Provisional agenda item 13.3 2 April 2001 Global health security - epidemic alert and response Report by the Secretariat INTRODUCTION

More information

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, WHO/NMH/PND/7.4 WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 207 Monitoring tobacco use and prevention policies Executive summary fresh and alive World Health Organization 207 Some rights reserved. This

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region Volume 8 Issue 8 ust 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 y 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed

More information

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008) August 2008 RESTRICTED MEBENDAZOLE Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008) REVISED DRAFT FOR ADOPTION This document was provided by a quality control

More information

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research SEA/CD/154 Distribution : General Avian Influenza in South-East Asia Region: Priority Areas for Research World Health Organization Publications of the World Health Organization enjoy copyright protection

More information

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region, Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed

More information

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010) August 2010 RESTRICTED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010) DRAFT FOR COMMENT This document was provided by a quality control expert and was

More information

2009 Report. Tuberculosis Control. in the Western Pacific Region

2009 Report. Tuberculosis Control. in the Western Pacific Region 2009 Report Tuberculosis Control in the Western Pacific Region Prepared by Dr Angelito Bravo was the lead author of this report. The following WHO staff from the regional and the country offices contributed

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region Volume 8 Issue 9 tember 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ust 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed

More information

preventing suicide Regional strategy on

preventing suicide Regional strategy on Over 800 000 people die due to suicide every year and there are many more who attempt suicide. Suicide was the second leading cause of death among 15-29 year olds globally in 2012. 75% of global suicide

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region Volume 8 Issue 10 ober 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 30 tember 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed

More information

EMTRICITABINE AND TENOFOVIR TABLETS

EMTRICITABINE AND TENOFOVIR TABLETS September 2010 RESTRICTED EMTRICITABINE AND TENOFOVIR TABLETS Draft proposal for The International Pharmacopoeia (September2010) REVISED DRAFT FOR COMMENT This document was provided by a quality control

More information

Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control

Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control The 7 th FAO/OIE Regional Steering Committee Meeting on GF-TADs for Asia and the Pacific 17-18 July 2013 Outline

More information

The OIE World Animal Health and Welfare Fund

The OIE World Animal Health and Welfare Fund The OIE World Animal Health and Welfare Fund Alain Dehove (DVM, MSc) Coordinator of the OIE World Fund a.dehove@oie.int OIE World Animal Health & Welfare Fund Created in 2004 by a resolution voted by OIE

More information

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems: Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems: National capabilities in public health systems Indonesia

More information

Preventing disease Promoting and protecting health

Preventing disease Promoting and protecting health Preventing disease Promoting and protecting health CONTENTS Context Global Health Security what is it? Health security the perfect storm Regional Health Security what is it? Caribbean Regional Health Security:

More information

WHO meeting on strengthening the measles and rubella laboratory network in the Russian Federation and newly independent states

WHO meeting on strengthening the measles and rubella laboratory network in the Russian Federation and newly independent states 20 22 May 2015 // St Petersburg, Russian Federation WHO meeting on strengthening the measles and rubella laboratory network in the Russian Federation and newly independent states KEYWORDS ACCREDITATION

More information

SECTOR ASSESMENT (SUMMARY): HEALTH

SECTOR ASSESMENT (SUMMARY): HEALTH Greater Mekong Subregion Health Security Project RRP REG-48118-002 SECTOR ASSESMENT (SUMMARY): HEALTH A. Sector Performance, Problems, and Opportunities 1. The governments of Cambodia, the Lao PDR, Myanmar,

More information

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region Volume 9 Issue 1 uary 2015 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ember 2014, WHO Western Pacific Region Legend: No confirmed case With confirmed case No

More information

Eighth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries

Eighth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries Summary report on the Eighth intercountry meeting of national malaria programme managers from HANMAT and PIAM-Net countries WHO-EM/MAL/384/E Islamabad, Pakistan 12 14 December 2016 Summary report on the

More information

RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic

RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic REMIGIO M. OLVEDA, MD Director IV Research Institute for Tropical Medicine-DOH Philippines RITM Pre-Pandemic Preparedness Plan Ongoing surveillance

More information

Pandemic preparedness in a changing world

Pandemic preparedness in a changing world Pandemic preparedness in a changing world Annual Conference on Disaster Preparedness and Response 2018 13 January 2018 Hong Kong, China Dr Li Ailan WHO Regional Emergency Director Preparing for a pandemic

More information

Measles cases MCV1 coverage MCV2 coverage

Measles cases MCV1 coverage MCV2 coverage Volume 7 Issue 9 tember 2013 ISSN 1814 3601 30 000 Figure 1. cases by month of onset, WHO Western Pacific Region, 2008 2013 1 Number of cases 25 000 20 000 15 000 10 000 5 000 0 2008 2009 2010 2011 2012

More information

hiv/aids Programme meeting report March 2012, Siem Reap, Cambodia Executive Summary

hiv/aids Programme meeting report March 2012, Siem Reap, Cambodia Executive Summary hiv/aids Programme meeting report WHO NIH Informal Consultation on Antiretroviral Treatment as HIV Prevention: Implementation Science in Asia 26-28 March 2012, Siem Reap, Cambodia Executive Summary WHO

More information

Foodborne disease outbreaks: Guidelines for investigation and control

Foodborne disease outbreaks: Guidelines for investigation and control Foodborne disease outbreaks: Guidelines for investigation and control WHO Library Cataloguing-in-Publication Data Foodborne disease outbreaks : guidelines for investigation and control. 1.Food contamination

More information

1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of

1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of INTERVENTION NOTES BY H.E. AMBASSADOR HAMIDON ALI, PERMANENT REPRESENTATIVE OF MALAYSIA TO THE UNITED NATIONS AT THE SPECIAL EVENT ON THE THEME OF AVIAN FLU, ORGANIZED BY THE ECONOMIC AND SOCIAL COUNCIL

More information